Testing blood and voice for early dementia diagnosis
Part of Brain & nervous system, Mental health clinical trials.
This study uses a simple blood test (neurofilament light chain) and a voice recording analysis to see if they can help diagnose dementia earlier. Researchers want to see if these markers can reliably detect brain changes in people with memory or thinking problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have concerns about your memory, thinking, or brain health.
- You are being seen at an Eastern Health hospital or clinic.
- Your doctor has not told you that you have less than 12 months to live.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study looks at different fluids from the body, like blood and tears, to find better ways to diagnose and track alzheimer's and related dementias. It compares people with these conditions to healthy volunteers to see what biological markers differ.
This study is for people on a memory clinic waiting list. It uses a simple blood test and remote thinking exercises to help doctors understand memory problems better and improve care.
This study is looking for older adults (60+) to help researchers better understand how to detect and track memory changes and dementia. Participants will provide blood samples and other health information over time to identify new markers that might help with early diagnosis.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.